World News

The new collaboration centres on CSPC’s small interfering RNA (siRNA) drug discovery platform and its proprietary delivery technology, which is designed to transport therapies beyond the liver.

Following the sale, Clarivate will concentrate on its Academia & Government (A&G) and Intellectual Property (IP) divisions.

The financing round was co-led by M Ventures, the venture capital arm of Merck KGaA, and GordonMD Global Investments.

Astex will also qualify for development, regulatory, and commercial milestone payments exceeding US$465 million, totaling US$490 million with the upfront payment included.

As part of the transaction, Besins Healthcare will take ownership of UniD Manufacturing’s production facility in Seraing, Belgium.

Founded in 2019 as a spinout from Imperial College London and the Francis Crick Institute, Myricx has attracted strong investor backing and has emerged as one of the UK’s leading oncology biotechnology companies.

Under the definitive agreement, which both companies’ boards unanimously approved, Vertex will pay US$85.00 in cash for each outstanding Crinetics share.

The agreement builds on Haleon’s existing use of Microsoft 365 Copilot and broadens the company’s adoption of Microsoft’s AI, cloud and data technologies.

Tregzi, also known as Orca-T, is an engineered allogeneic cell therapy used alongside matched-donor hematopoietic stem cell transplantation.

The expanded label is expected to make about 5,500 additional children in the United States eligible for treatment.